Seelos Therapeutics is leading the charge against central nervous system (CNS) disorders by advancing late-stage therapeutic candidates with proven mechanisms of action for patients with suicidality in post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). And Mario Nacinovich welcomes Dr. Raj Mehra, Chairman, Founder, and CEO of Seelos Therapeutics, to hear all about it.
